2024 Q3 Form 10-Q Financial Statement

#000147793224005119 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $235.4K $4.095K
YoY Change -95.96% -99.79%
Cost Of Revenue $2.661M $677.3K
YoY Change 126.02% -84.23%
Gross Profit -$2.426M -$673.2K
YoY Change -152.16% -70.91%
Gross Profit Margin -1030.37% -16439.07%
Selling, General & Admin $4.367M $3.279M
YoY Change 163.25% 121.37%
% of Gross Profit
Research & Development $78.81K $1.198M
YoY Change -94.08% -55.07%
% of Gross Profit
Depreciation & Amortization $584.1K $519.4K
YoY Change 6236.33% 6024.09%
% of Gross Profit
Operating Expenses $8.494M $6.234M
YoY Change 79.32% -30.83%
Operating Profit -$8.258M -$6.229M
YoY Change -856.26% -11.39%
Interest Expense $774.5K $418.5K
YoY Change 158.36% 149.36%
% of Operating Profit
Other Income/Expense, Net -$963.9K -$371.3K
YoY Change -140.3% -106.16%
Pretax Income -$9.222M -$6.601M
YoY Change -364.73% 560.12%
Income Tax
% Of Pretax Income
Net Earnings -$9.222M -$6.601M
YoY Change -364.73% 560.12%
Net Earnings / Revenue -3916.97% -161190.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.12 -$0.09
COMMON SHARES
Basic Shares Outstanding 77.42M shares 79.18M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $991.7K $554.4K
YoY Change -68.19% -80.71%
Cash & Equivalents $840.3K $554.4K
Short-Term Investments $151.3K $0.00
Other Short-Term Assets $1.866M $1.866M
YoY Change -2.69% 3.29%
Inventory $2.030M $2.030M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.715M $4.450M
YoY Change -53.74% -30.33%
LONG-TERM ASSETS
Property, Plant & Equipment $17.49M $42.36M
YoY Change 49.64% 369.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.219M $1.884M
YoY Change -68.08% -90.11%
Other Assets $160.8M $169.0M
YoY Change 76.08% 80.38%
Total Long-Term Assets $205.9M $191.1M
YoY Change 127.33% 103.93%
TOTAL ASSETS
Total Short-Term Assets $5.715M $4.450M
Total Long-Term Assets $205.9M $191.1M
Total Assets $211.6M $195.5M
YoY Change 105.6% 95.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.75M $7.307M
YoY Change 148.19% 0.09%
Accrued Expenses $514.8K $495.9K
YoY Change 260.33% 247.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $804.7K $804.7K
YoY Change 0.0% -1.71%
Total Short-Term Liabilities $24.61M $19.27M
YoY Change 51.83% 18.9%
LONG-TERM LIABILITIES
Long-Term Debt $212.8M $193.3M
YoY Change 392.47% 344.63%
Other Long-Term Liabilities $28.62M $28.56M
YoY Change -0.68% -3.72%
Total Long-Term Liabilities $241.4M $221.9M
YoY Change 235.17% 203.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.61M $19.27M
Total Long-Term Liabilities $241.4M $221.9M
Total Liabilities $266.0M $241.1M
YoY Change 201.49% 169.9%
SHAREHOLDERS EQUITY
Retained Earnings -$234.6M -$226.1M
YoY Change 43.18% 35.12%
Common Stock $7.742K $7.742K
YoY Change 1.51% 1.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$51.83M -$44.08M
YoY Change
Total Liabilities & Shareholders Equity $212.6M $195.5M
YoY Change 106.57% 95.36%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$9.222M -$6.601M
YoY Change -364.73% 560.12%
Depreciation, Depletion And Amortization $584.1K $519.4K
YoY Change 6236.33% 6024.09%
Cash From Operating Activities -$3.099M -$5.086M
YoY Change -0.92% -453.03%
INVESTING ACTIVITIES
Capital Expenditures $383.9K
YoY Change 768.85%
Acquisitions
YoY Change
Other Investing Activities $1.358M -$3.662M
YoY Change -416.71% -1564.85%
Cash From Investing Activities $2.007M -$4.046M
YoY Change -158.96% -2065.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.003M -479.0K
YoY Change 250.66% -101.01%
NET CHANGE
Cash From Operating Activities -3.099M -5.086M
Cash From Investing Activities 2.007M -4.046M
Cash From Financing Activities -1.003M -479.0K
Net Change In Cash -2.096M -9.611M
YoY Change -69.26% -119.57%
FREE CASH FLOW
Cash From Operating Activities -$3.099M -$5.086M
Capital Expenditures $383.9K
Free Cash Flow -$5.470M
YoY Change -491.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
13545365 usd
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
554416 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2906257 usd
CY2024Q2 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
168998842 usd
CY2023Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
33774385 usd
CY2024Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
169553258 usd
CY2023Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
36680642 usd
us-gaap Change In Accounting Estimate Description
ChangeInAccountingEstimateDescription
We are using discount rates ranging from 6.16% to 7.22%, risk free rates ranging from 1.76% to 2.92% and inflation rate of 2%
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
20295634 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1489746 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
993165 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
21785380 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
21288799 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
253764 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42356775 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41714649 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23165784 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21479525 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8736 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
27126 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
50122 usd
CY2024Q2 arec Accretion Of Operating Lease Liability
AccretionOfOperatingLeaseLiability
37629 usd
CY2023Q2 arec Accretion Of Operating Lease Liability
AccretionOfOperatingLeaseLiability
65753 usd
CY2024Q1 arec Operating Leases Percent
OperatingLeasesPercent
0.1100 pure
CY2023 arec Operating Leases Percent
OperatingLeasesPercent
0.1100 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001590715
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 174
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
230000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77400289 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76247370 shares
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55456
dei Entity Registrant Name
EntityRegistrantName
AMERICAN RESOURCES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3914127
dei Entity Address Address Line1
EntityAddressAddressLine1
12115 Visionary Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Fishers
dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46038
dei City Area Code
CityAreaCode
317
dei Local Phone Number
LocalPhoneNumber
855-9926
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77422390 shares
CY2024Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
19190991 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
15337004 usd
CY2024Q2 arec Long Term Right Of Use Assets Net
LongTermRightOfUseAssetsNet
616045 usd
CY2023Q4 arec Long Term Right Of Use Assets Net
LongTermRightOfUseAssetsNet
18276913 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76247370 shares
CY2024Q2 arec Stockholder Equity Including Portion Attributable To Noncontrolling Interest
StockholderEquityIncludingPortionAttributableToNoncontrollingInterest
-45615847 usd
CY2023Q4 arec Stockholder Equity Including Portion Attributable To Noncontrolling Interest
StockholderEquityIncludingPortionAttributableToNoncontrollingInterest
223844 usd
CY2024Q2 arec Cost Of Coal Sales And Processing
CostOfCoalSalesAndProcessing
507596 usd
CY2023Q2 arec Cost Of Coal Sales And Processing
CostOfCoalSalesAndProcessing
3798012 usd
arec Cost Of Coal Sales And Processing
CostOfCoalSalesAndProcessing
1197775 usd
arec Cost Of Coal Sales And Processing
CostOfCoalSalesAndProcessing
6503830 usd
arec Non Cash Transaction Dividend In Kind Of Novustera Inc Common Stock To Shareholders
NonCashTransactionDividendInKindOfNovusteraIncCommonStockToShareholders
1361788 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
CY2024Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
arec Share Purchase Agreement Description
SharePurchaseAgreementDescription
where ACC has purchased 51% of the fully diluted shares outstanding of TR Mining in exchange for approximately 6% of the primary shares outstanding of ACC. The assets of TR Mining include a diversified mineral deposit with a focus on iron ore, titanium and vanadium with an initial estimated deposit of 212,925,000 tons of raw feedstock with an estimated 106,462,500 tons of ore body, based on an average of 50% magnetic material
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-20584563 usd
CY2023Q1 arec Issuance Of Common Shares For Convertible Debt Conversion Amount
IssuanceOfCommonSharesForConvertibleDebtConversionAmount
9787423 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
629877 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2862824 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13030087 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
740811 usd
CY2023Q2 arec Recapture Expenses For Bond Issuance
RecaptureExpensesForBondIssuance
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7821016 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-20110292 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-32804761 usd
CY2024Q1 arec Exercise Of Cashless Warrants Amount
ExerciseOfCashlessWarrantsAmount
0 usd
CY2024Q1 arec Exercise Of Stock Options Amount
ExerciseOfStockOptionsAmount
156900 usd
CY2024Q1 arec Issuance Of Common Shares For Consulting Services Amount
IssuanceOfCommonSharesForConsultingServicesAmount
43800 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
889173 usd
CY2024Q1 arec Dividend In Kind Of Novustera Inc Common Stock To Shareholders
DividendInKindOfNovusteraIncCommonStockToShareholders
-1361788 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6305692 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-40021289 usd
CY2024Q2 arec Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
32339 usd
CY2024Q2 arec Issuance Of Common Shares For Consulting Services Amount
IssuanceOfCommonSharesForConsultingServicesAmount
99775 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
874080 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6600752 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-45615847 usd
arec Profit And Loss
ProfitAndLoss
13545365 usd
arec Profit And Loss
ProfitAndLoss
4100794 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1069559 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
21818 usd
arec Amortization Of Mining Rights
AmortizationOfMiningRights
623370 usd
arec Amortization Of Mining Rights
AmortizationOfMiningRights
617544 usd
arec Accretion Expenses
AccretionExpenses
496581 usd
arec Accretion Expenses
AccretionExpenses
496580 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
27126 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
695933 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54315 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
arec Investment In Other Entities Related Parties
InvestmentInOtherEntitiesRelatedParties
231360 usd
arec Investment In Other Entities Related Parties
InvestmentInOtherEntitiesRelatedParties
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
400000 usd
arec Issuance Of Common Shares For Services
IssuanceOfCommonSharesForServices
0 usd
arec Noncash Stock Based Compensation Expense
NoncashStockBasedCompensationExpense
1763253 usd
arec Noncash Stock Based Compensation Expense
NoncashStockBasedCompensationExpense
753146 usd
arec Issuance Of Common Shares For Services
IssuanceOfCommonSharesForServices
143575 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-334475 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1975812 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-264536 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1651 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1019982 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1852196 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-321661 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27781 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-35996 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
142471 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1733216 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25217 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13217548 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6617505 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
648796 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-1726273 usd
arec Proceeds Received From Other Financing Obligation
ProceedsReceivedFromOtherFinancingObligation
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
-553105 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-248796 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1173168 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
32339 usd
arec Cashless Warrants Exercises
CashlessWarrantsExercises
0 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1098821 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
156900 usd
arec Non Cash Transaction Dividend In Kind Of Novustera Inc Common Stock To Shareholders
NonCashTransactionDividendInKindOfNovusteraIncCommonStockToShareholders
0 usd
us-gaap Proceeds From Issuance Of Secured Tax Exempt Debt
ProceedsFromIssuanceOfSecuredTaxExemptDebt
149719203 usd
us-gaap Proceeds From Issuance Of Secured Tax Exempt Debt
ProceedsFromIssuanceOfSecuredTaxExemptDebt
43475887 usd
arec Proceeds Received From Other Financing Obligation
ProceedsReceivedFromOtherFinancingObligation
4011025 usd
arec Repayments Of Other Financing Obligation
RepaymentsOfOtherFinancingObligation
3569482 usd
arec Repayments Of Other Financing Obligation
RepaymentsOfOtherFinancingObligation
1116969 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
146338960 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45271122 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
132872616 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40542101 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36680642 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10990829 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169553258 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51532930 usd
arec Cashless Warrants Exercises
CashlessWarrantsExercises
87 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3814336 usd
arec Non Cash Transaction Dividend In Kind Of Novustera Inc Common Stock To Shareholders
NonCashTransactionDividendInKindOfNovusteraIncCommonStockToShareholders
1361788 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
arec Investment In Other Entities Related Parties
InvestmentInOtherEntitiesRelatedParties
0 usd
CY2024Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
arec Share Purchase Agreement Description
SharePurchaseAgreementDescription
where ACC has purchased 51% of the fully diluted shares outstanding of TR Mining in exchange for approximately 6% of the primary shares outstanding of ACC. The assets of TR Mining include a diversified mineral deposit with a focus on iron ore, titanium and vanadium with an initial estimated deposit of 212,925,000 tons of raw feedstock with an estimated 106,462,500 tons of ore body, based on an average of 50% magnetic material
us-gaap Net Income Loss
NetIncomeLoss
10683840 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226097239 usd
us-gaap Net Income Loss
NetIncomeLoss
10683840 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226097239 usd
CY2023Q2 arec Accretion Expenses On Aro
AccretionExpensesOnAro
248292 usd
arec Accretion Expenses On Aro
AccretionExpensesOnAro
496584 usd
CY2024Q2 arec Accretion Expenses On Aro
AccretionExpensesOnAro
248291 usd
arec Accretion Expenses On Aro
AccretionExpensesOnAro
496582 usd
CY2023Q2 arec Accretion Expenses On Aro
AccretionExpensesOnAro
248292 usd
arec Accretion Expenses On Aro
AccretionExpensesOnAro
496584 usd
CY2024Q2 arec Accretion Expenses On Aro
AccretionExpensesOnAro
248291 usd
arec Accretion Expenses On Aro
AccretionExpensesOnAro
496582 usd
CY2024Q2 arec Allowance For Doubtful Accounts Note Receivable Current
AllowanceForDoubtfulAccountsNoteReceivableCurrent
0 usd
CY2023Q4 arec Allowance For Doubtful Accounts Note Receivable Current
AllowanceForDoubtfulAccountsNoteReceivableCurrent
368500 usd
arec Available For Sale On Cost Basis Securities Unrealized
AvailableForSaleOnCostBasisSecuritiesUnrealized
251008 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
0 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
166 usd
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0 usd
CY2024Q2 arec Available For Sale Fair Values
AvailableForSaleFairValues
250842 usd
CY2023 arec Available For Sale On Cost Basis Securities Unrealized
AvailableForSaleOnCostBasisSecuritiesUnrealized
1342417 usd
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
5491 usd
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 usd
CY2023 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0 usd
CY2023Q4 arec Available For Sale Fair Values
AvailableForSaleFairValues
1347908 usd
CY2024Q1 arec Investments Description
InvestmentsDescription
maturity dates ranging from the second quarter of 2024 through the second quarter of 2025.
CY2024Q2 arec Allowance For Doubtful Accounts Note Receivable Current
AllowanceForDoubtfulAccountsNoteReceivableCurrent
0 usd
CY2023Q4 arec Allowance For Doubtful Accounts Note Receivable Current
AllowanceForDoubtfulAccountsNoteReceivableCurrent
368500 usd
arec Available For Sale On Cost Basis Securities Unrealized
AvailableForSaleOnCostBasisSecuritiesUnrealized
251008 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
0 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
166 usd
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0 usd
CY2024Q2 arec Available For Sale Fair Values
AvailableForSaleFairValues
250842 usd
CY2023 arec Available For Sale On Cost Basis Securities Unrealized
AvailableForSaleOnCostBasisSecuritiesUnrealized
1342417 usd
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
5491 usd
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 usd
CY2023 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0 usd
CY2023Q4 arec Available For Sale Fair Values
AvailableForSaleFairValues
1347908 usd
CY2024Q1 arec Investments Description
InvestmentsDescription
maturity dates ranging from the second quarter of 2024 through the second quarter of 2025.
CY2024Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
250842 usd
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
1347908 usd
arec Rental Lease Expiration Date
RentalLeaseExpirationDate
December 2031
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
64755 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
92501 usd
CY2024Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
250842 usd
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
1347908 usd
arec Rental Lease Expiration Date
RentalLeaseExpirationDate
December 2031
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
92501 usd
CY2024Q1 arec Operating Leases In Years
OperatingLeasesInYears
P8Y
CY2023 arec Operating Leases In Years
OperatingLeasesInYears
P7Y9M
CY2020Q2 arec Purchase Secured Debt
PurchaseSecuredDebt
1494570 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
804656 usd
CY2020Q2 arec Purchase Secured Debt
PurchaseSecuredDebt
1494570 usd
arec Investments In Other Entities Related Parties Textblock
InvestmentsInOtherEntitiesRelatedPartiesTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 7 - INVESTMENTS IN OTHER ENTITIES - RELATED PARTIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for its investments and membership interest in other entities under the equity method of accounting if the Company has the ability to exercise significant influence, but not control, over the entity. Equity method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the investments may not be recoverable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Royalty Management Co.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During January 2021, the company invested $2,250,000 for 50% ownership and became the managing member of American Opportunity Venture, LLC. (AOV) It has been determined that AOV is a variable interest entity and that the Company is the primary beneficiary, therefore AOV has been consolidated into the Company’s financial statement. As such, AOV’s sole investment in Royalty Management Co (RMCO) will be accounted for using the equity method of accounting. The sole investment was initially in American Acquisition Opportunity Inc (AMAO) a SPAC that closed its reverse merger with RMCO effective October 31, 2023. The Company recognizes the earnings or losses on a three-month lag to ensure consistency and timely filling of the Company’s financial statements. As of June 30, 2024 December 31, 2023, the Company held 3,076,500 shares of Class A common stock in RMCO.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Novusterra, Inc.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 31, 2021, the Company entered into a Graphene Development Agreement with Novusterra, Inc (Novusterra), a related party, that provided a nonexclusive sublicense for fifty percent (50%) of the operating profits from Novustera’s Graphene manufacturing and marketing business activity. As part of the agreement, Novusterra’s Chairman of the Board of Directors at the time was replaced by the Company’s Mark Jensen, Chief Executive Officer and Chairman of the Board of Directors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 30, 2022, we entered into a purchase agreement to sell the exclusive rights of the patent patents included in the Graphene Development Agreement for 4,000,000 common shares of Novusterra with a fair market value of $1,784,000 in stock of Novusterra. As part of the sale of the exclusive rights to the patents, Andrew Weeraratne resigned as director and CEO of Novusterra and Gregory Jensen, the Company’s general counsel, joined Novusterra as CEO and Director and Mark Jensen resigned as Chairman of the Board of Directors. Pursuant to the purchase agreement, Novusterra is no longer obligated to pay the Company fifty percent (50%) of the operating profits from their Graphene manufacturing and marketing business. However, Novusterra is still obligated to pay the Company ten percent (10%) of all revenue from the exclusive sublicense with Kenai Defense Company, LLC and for the Department of Defense under the contract that was transferred from the Company to Novusterra. Any subsequent contracts entered into by Novusterra with Kenai Defense Company, LLC and for the Department of Defense will have no future revenue allocations to the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">It has been determined that Novusterra is a variable interest entity and that the Company is not the primary beneficiary. As such, the investment in Novusterra has been accounted for using the equity method of accounting. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective March 6, 2024, the Company issued a special dividend to all stockholders on record of 91% of the Company’s ownership in Novusterra, Inc. resulting in the Company to receive 9% of future cash flows and holding 360,000 common shares of Novusterra, Inc. Due to the Company new ownership in Novusterra, Inc. the investment is accounted for using the cost method of accounting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">FUB Mineral LLC</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 1, 2021, the Company contributed $250,000 for a 23% ownership in FUB Mineral LLC (FUB). Simultaneously the Company issued a promissory note FUB for $350,000, this note was fully repaid as of April 15, 2022. On February 2, 2022, the Company issued a new promissory note for $535,000 to FUB with an interest rate of 10% and maturity date of February 1, 2023, which has been extended by the Company through the end of August 2024. As of June 30, 2024 and December 31, 2023, the Company had a note receivable balance of $379,022 and $379,022, respectively.</p>
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
804656 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
804656 usd
arec Scheduleoftax Exempt Bonds Bear Interestttabletextblock
ScheduleoftaxExemptBondsBearInterestttabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30</strong><strong>, </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax Exempt Bonds ($45 million face value)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax Exempt Bonds ($150 million face value)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt issuance costs and debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,691,323 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,464,841 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Bonds payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">193,308,677</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">43,535,159</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Bonds payable, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">193,308,677</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">43,535,159</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q2 arec Debt Issuance Costs And Debt Discount
DebtIssuanceCostsAndDebtDiscount
-1691323 usd
CY2023Q4 arec Debt Issuance Costs And Debt Discount
DebtIssuanceCostsAndDebtDiscount
-1464841 usd
CY2024Q2 arec Notes Payable Gross
NotesPayableGross
193308677 usd
CY2023Q4 arec Notes Payable Gross
NotesPayableGross
43535159 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2024Q2 arec Notes Payable Net
NotesPayableNet
193308677 usd
CY2023Q4 arec Notes Payable Net
NotesPayableNet
43535159 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
804656 usd
arec Scheduleoftax Exempt Bonds Bear Interestttabletextblock
ScheduleoftaxExemptBondsBearInterestttabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30</strong><strong>, </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax Exempt Bonds ($45 million face value)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax Exempt Bonds ($150 million face value)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt issuance costs and debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,691,323 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,464,841 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Bonds payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">193,308,677</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">43,535,159</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Bonds payable, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">193,308,677</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">43,535,159</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q2 arec Debt Issuance Costs And Debt Discount
DebtIssuanceCostsAndDebtDiscount
-1691323 usd
CY2023Q4 arec Debt Issuance Costs And Debt Discount
DebtIssuanceCostsAndDebtDiscount
-1464841 usd
CY2024Q2 arec Notes Payable Gross
NotesPayableGross
193308677 usd
CY2023Q4 arec Notes Payable Gross
NotesPayableGross
43535159 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2024Q2 arec Notes Payable Net
NotesPayableNet
193308677 usd
CY2023Q4 arec Notes Payable Net
NotesPayableNet
43535159 usd

Files In Submission

Name View Source Status
0001477932-24-005119-index-headers.html Edgar Link pending
0001477932-24-005119-index.html Edgar Link pending
0001477932-24-005119.txt Edgar Link pending
0001477932-24-005119-xbrl.zip Edgar Link pending
arec-20240630.xsd Edgar Link pending
arec_10q.htm Edgar Link pending
arec_ex211.htm Edgar Link pending
arec_ex311.htm Edgar Link pending
arec_ex312.htm Edgar Link pending
arec_ex321.htm Edgar Link pending
arec_ex322.htm Edgar Link pending
arec_ex951.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
arec-20240630_cal.xml Edgar Link unprocessable
arec-20240630_pre.xml Edgar Link unprocessable
arec-20240630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arec_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arec-20240630_def.xml Edgar Link unprocessable